With 52049.0 shares changed hands, the volume of the stock remained lighter than its average volume of 0.19 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.2 whereas the lowest price it dropped to was $1.09. The 52-week range on APM shows that it touched its highest point at $7.49 and its lowest point at $0.69 during that stretch. It currently has a 1-year price target of $80.00. Beta for the stock currently stands at -0.17.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of APM was up-trending over the past week, with a rise of 6.36%, but this was down by -10.69% over a month. Three-month performance dropped to -34.64% while six-month performance rose 18.18%. The stock lost -58.21% in the past year, while it has gained 58.13% so far this year.
Float and Shares Shorts:
At present, 5.35 million APM shares are outstanding with a float of 5.31 million shares on hand for trading. On 2025-11-28, short shares totaled 26279.0, which was 32.0 higher than short shares on 1761868800. In addition to Mr. Chung Yuen Huen as the firm’s Founder, CEO & Executive Director, Mr. Kwok Kuen Wong serves as its Head of Finance.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.7 being high and -$0.7 being low. For APM, this leads to a yearly average estimate of -$0.7.
